Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin-Fa Wang

Showing results (341-350 of 433) with videos related to

Pageof 44
Sort By:
Nature Microbiology|March 27, 2026
An emerging human eye disease is associated with aquatic virus zoonotic infectionShuang Liu, Die Hu, Tingting Xu, et al.
Journal of Virology|January 25, 2013
Promotion of Hendra virus replication by microRNA 146aCameron R Stewart, Glenn A Marsh, Kristie A Jenkins, et al.
Emerging Infectious Diseases|February 28, 2014
Hendra virus vaccine, a one health approach to protecting horse, human, and environmental healthDeborah Middleton, Jackie Pallister, Reuben Klein, et al.
The Journal of Infection|September 6, 2022
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodiesLydia Su Yin Wong, Evelyn Xiu Ling Loo, Chiung-Hui Huang, et al.
Rheumatology (Oxford, England)|January 20, 2023
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseasesJoo Guan Yeo, Kai Liang Teh, Wan Ni Chia, et al.
Archives of Virology|May 3, 2013
Nyamiviridae: proposal for a new family in the order MononegaviralesJens H Kuhn, Sadia Bekal, Yíngyún Caì, et al.
Trials|June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 1, 2024
COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infectionAniza P Mahyuddin, Hannah L F Swa, Ruifen Weng, et al.
Mbio|January 18, 2022
Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection <i>In Vitro</i>, despite Eliciting a Prolonged Antiviral ResponseAkshamal M Gamage, Kai Sen Tan, Wharton O Y Chan, et al.
Nature Communications|September 26, 2025
A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferationSiwy Ling Yang, Louis DeFalco, Sainan Wang, et al.
Pageof 44

Showing results (341-350 of 433) with videos related to

Sort By:
Pageof 44
Nature Microbiology|March 27, 2026
An emerging human eye disease is associated with aquatic virus zoonotic infectionShuang Liu, Die Hu, Tingting Xu, et al.
Journal of Virology|January 25, 2013
Promotion of Hendra virus replication by microRNA 146aCameron R Stewart, Glenn A Marsh, Kristie A Jenkins, et al.
Emerging Infectious Diseases|February 28, 2014
Hendra virus vaccine, a one health approach to protecting horse, human, and environmental healthDeborah Middleton, Jackie Pallister, Reuben Klein, et al.
The Journal of Infection|September 6, 2022
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodiesLydia Su Yin Wong, Evelyn Xiu Ling Loo, Chiung-Hui Huang, et al.
Rheumatology (Oxford, England)|January 20, 2023
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseasesJoo Guan Yeo, Kai Liang Teh, Wan Ni Chia, et al.
Archives of Virology|May 3, 2013
Nyamiviridae: proposal for a new family in the order MononegaviralesJens H Kuhn, Sadia Bekal, Yíngyún Caì, et al.
Trials|June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 1, 2024
COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infectionAniza P Mahyuddin, Hannah L F Swa, Ruifen Weng, et al.
Mbio|January 18, 2022
Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection <i>In Vitro</i>, despite Eliciting a Prolonged Antiviral ResponseAkshamal M Gamage, Kai Sen Tan, Wharton O Y Chan, et al.
Nature Communications|September 26, 2025
A conserved long-range RNA interaction in SARS-CoV-2 recruits ADAR1 to enhance virus proliferationSiwy Ling Yang, Louis DeFalco, Sainan Wang, et al.
Pageof 44